The value of immunoscintigraphy in the detection of recurrent colorectal cancer

Nuclear Medicine Communications

Volumn 22, Issue 12, 2001, Pages 1295-1304

  Baulieu, F ^a   Bourlier, P ^a   Scotto, B ^a   Mor, C ^a   Eder, V ^a   Picon, L ^a   De Calan, L ^a   Dorval, E ^a   Pottier, J M ^a   Baulieu, J L ^a  

^a UNIVERSITY HOSPITAL OF TOURS   (France)

Author keywords

CEA Scan; Colo rectal cancer; Immunoscintigraphy

Indexed keywords

ARCITUMOMAB TC 99M;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; COLORECTAL CANCER; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DIAGNOSTIC VALUE; FEMALE; HUMAN; IMMUNOSCINTIGRAPHY; LIVER METASTASIS; MALE; PERITONEUM CANCER; RECURRENT CANCER;

ADENOCARCINOMA; ADULT; AGED; ANTIBODIES, MONOCLONAL; CARCINOEMBRYONIC ANTIGEN; COLORECTAL NEOPLASMS; FEMALE; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; RADIOIMMUNODETECTION; RECTAL NEOPLASMS; RECURRENCE; TECHNETIUM; TISSUE DISTRIBUTION; TOMOGRAPHY, X-RAY COMPUTED; TUMOR MARKERS, BIOLOGICAL;

EID: 0035204324     PISSN: 01433636     EISSN: 14735628     Source Type: Journal    
DOI: 10.1097/00006231-200112000-00004     Document Type: Review

References (34)

1. Menegoz F, Black RJ, Arveux P, et al. Cancer incidence and mortality in France in 1975-95. Eur J Cancer Prev 1997; 6: 442-466.
2. Hugues K, Pinsky CM, Petrelli NJ, et al. Use of carcinoembryonic antigen radioimmunodetection and computed tomography for predicting the resectability of recurrent colorectal cancer. Ann Surgery 1997; 226: 621-631.
3. Gold P, Freedman SO. Specific carcinoembryonic antigens of the human digestive system. J Exper Med 1965; 122: 467-481.
4. Goldenberg DM, DeLand F, Kim E. Use of radiolabeled antibodies to carcinoembryonic antigen for the detection and localization of diverse cancers by external photoscanning. N Engl J Med 1978; 298: 1384-1388.
5. Mach JP, Carrel S, Forni M, Ritschard J, Donath A, Alberto P. Tumor localization of radiolabeled antibodies against carcinoembryonic antigen in patients with carcinoma. N Engl J Med 1980; 303: 5-10.
6. Kohler G, Milstein C. Continuous culture of fused cells secreting antibody of predefined specificity. Nature 1975; 265: 495-496.
7. Bischof Delaloye A, Delaloye B. Tumor imaging with monoclonal antibodies. Semin Nucl Med 1995; 25: 144-164.
8. Collier BD, Abdel-Nabi H, Doerr RJ, et al. Immunoscintigraphy performed with In-111-labeled CYT-103 in the management of colorectal cancer: comparison with CT. Radiology 1992; 185: 179-186.
9. Bischof Delaloye A. Radioimmunoimaging and radioimmunotherapy: will these be routine procedures? Semin Nucl Med 2000; 3: 186-194.
10. m-Immu4 imaging in recurrent colorectal cancer: efficacy and impact on surgical management. Nucl Med Commun 1996; 17: 568-576.
11. Granowska M, Britton KE, Mather SJ, et al. Radioimmunoscintigraphy with technetium-99m labelled monoclonal antibody, 1A3, in colorectal cancer. Eur J Nucl Med 1993; 20: 690-698.
12. Lunniss PJ, Skinner S, Britton KE, Granowska M, Morris G, Northover MA. Effect of radioimmunoscintigraphy on the management of recurrent colorectal cancer. Br J Surg 1999, 86: 244-249.
13. m-labelled monoclonal anti-CEA BW 431/26 antibodies in patients with suspected recurrent and metastatic colorectal carcinoma: two-year follow-up. Nucl Med Commun 1999; 20: 859-865.
14. 99mTc: the role of metabolism and kinetics. Cancer Res 1995; 55(Suppl.): 5777s-5785s.
15. 99mTc-labeled anti-carcinoembryonic antigen antibodies: an intraindividual comparison. Cancer Res 1995; 55(Suppl.): 5786s-5793s.
16. Behr T, Becker W, Bair HJ, Klein M, et al. Comparison of complete versus fragmented technetium-99m labeled anti-CEA monoclonal antibodies for immunoscintigraphy in colorectal cancer. J Nucl Med 1995; 36: 430-441.
17. Lorenz R, Krestin GP, Neufang KF. Diagnosis and differential diagnosis of a peritoneal carcinosis. Conventional techniques, sonography, computed tomography, magnetic resonance tomography. Radiologe 1990; 30: 477-480.
18. Sugarbaker PH. Surgical management of peritoneal carcinosis: diagnosis, prevention and treatment. Langenbecks Arch Chir 1988; 373: 189-196.
19. Scharling ES, Wolfman NT, Bechtold E. Computed tomography evaluation of colorectal carcinoma. Semin Roentgen 1996; 31: 142-153.
20. TM) in primary and recurrent colorectal cancer. Dis Colon Rectum 1993; 36: 930-935.
21. Patt YZ, Podoloff DA, Curley S, et al. Monoclonal antibody imaging in patients with colorectal cancer and increasing levels of serum carcinoembryonic antigen. Cancer 1993; 71: 4293-4297.
22. Moffat FL, Pinsky CM, Hammershaimb L, et al. Clinical utility of external immunoscintigraphy with the IMMU-4 technetium-99m Fab′ antibody fragment in patients undergoing surgery for carcinoma of the colon and rectum: results of a pivotal, phase III trial. J Clin Oncol 1996; 14: 2295-2305.
23. 99mTc-markierten anti-CEA-Fab′-fragmenten in der nachsorge des kolorektalen karzinoms. Dtsch med Wschr 1997; 122: 463-470.
24. Stomper PC, D’Souza DJ, Bakshi SP, Rodriguez-Bigas M, Burke PA, Petrelli NJ. Detection of pelvic recurrence of colorectal carcinoma: prospective, blinded comparison of Tc-99m-IMMU-4 monoclonal antibody scanning and CT. Radiology 1995; 197: 688-692.
25. 111In-labeled B72.3 monoclonal antibody. Cancer Res 1990; 50(Suppl.): 932-936.
26. Bock E, Becker W, Scheele J, Wolf F. Diagnostic accuracy of 99mTc-anti-CEA immunoscintigraphy in patients with liver metastases from colorectal carcinoma. Nucl Med 1992; 31: 80-83.
27. Steinstraber A, Oberhausen E. Anti-CEA labelling kit BW 431/26. Results of the European Multicenter Trial. Nucl Med 1995; 34: 232-242.
28. 18F-fluorodeoxyglucose in the management of recurrent colorectal cancer. Arch Surg 1999; 134: 503-511.
29. Fong Y, Saldinger PF, Akhurst T, et al. Utility of 18F-FDG positron emission tomography scanning on selection of patients for resection of hepatic colorectal metastases. Am J Surg 1999; 178: 282-287.
30. Whiteford MH, Whiteford HM, Yee LF, et al. Usefulness of FDG-PET scan in the assessment of suspected metastatic or recurrent adenocarcinoma of the colon and rectum. Dis Colon Rectum 2000; 43: 759-767.
31. Huebner RH, Park KC, Shepherd JE, et al. A meta-analysis of the literature for whole-body FDG PET detection of recurrent colorectal cancer. J Nucl Med 2000; 41: 1177-1189.
32. 99mTc-labeled antibody fragments for detection of the recurrence of colorectal carcinoma. J Nucl Med 2000; 41: 1657-1663.
33. Winthrop MD, Denardo GL, Denardo SJ. Antibody phage display applications for nuclear medicine imaging and therapy. Q J Nucl Med 2000; 44: 284-295.
34. Sundaresan G, Yazaki PJ, Shively JE, et al. I-124 radiolabelled genetically engineered anti-CEA antibody fragments for tumor imaging with micropet. J Nucl Med 2001; 42: 153P.